ArticleBlood2021

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.

Sonali Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.